LncRNA Expression Profiles in C6 Ceramide Treatment Reveal lnc_025370 as a Promoter in Canine Mammary Carcinoma CHMp Cells Progression
Author Information
Author(s): Diao Hongxiu, Zhao Fangying, Wu Meijin, Zhang Yan, Tao Qianting, Chen Shichao, Lin Degui, Jayakumar Arumugam R.
Primary Institution: Fujian Agriculture and Forestry University
Hypothesis
C6 ceramide treatment affects lncRNA expression profiles in canine mammary carcinoma cells.
Conclusion
Lnc_025370 promotes the growth and metastasis of CHMp cells and is downregulated by C6 ceramide treatment.
Supporting Evidence
- C6 ceramide treatment significantly inhibits the proliferation of CHMp cells.
- RNA sequencing identified 4522 lncRNAs with expression changes following C6 ceramide treatment.
- Overexpression of Lnc_025370 enhances the growth and metastatic capabilities of CHMp cells.
- Mouse xenograft models showed that Lnc_025370 overexpression promotes tumor growth.
Takeaway
This study found that a specific RNA, Lnc_025370, helps cancer cells grow and spread, and that a treatment called C6 ceramide can lower its levels.
Methodology
RNA sequencing was used to identify differentially expressed lncRNAs, followed by in vitro and in vivo experiments to confirm the regulatory role of Lnc_025370.
Limitations
The specific mechanism by which LncRNA_025370 regulates NRG1 remains unclear, and validation in dog patients is lacking.
Participant Demographics
The CHMp cell line originated from a 12-year-old female dog of mixed breed.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website